Create Account | Sign In: Author or Forum

Search Symptoms


Adjuvant Pembrolizumab Beneficial in Stage III Melanoma

April 16, 2018. 12:00 PM CDT. Pembrolizumab linked to significantly longer recurrence-free survival at 15-month follow-up Read article


Adjuvant Nivolumab Tops Ipilimumab in Melanoma

September 12, 2017 Longer recurrence-free survival for stage IIIB, IIIC, IV melanoma

Rates of S. aureus Antibiotic Resistance Down in United States

June 15, 2017 Rates of susceptibility to certain antibiotics have increased over time

Acne May Be Triggered by Unbalanced Skin Microbiome

April 06, 2017 Barcterial community, rather than just one species, may be key, new research suggests

Dupilumab Effective in Atopic Dermatitis

October 03, 2016 Primary outcome occurred significantly more often for patients receiving dupilumab in SOLO 1, SOLO 2

Early Exposure to Antibiotics Ups Risk of Allergic Dz Later in Life

September 07, 2016 Researchers found higher risk for hay fever, eczema in those exposed to antibiotics before age 2

Psoriasis Patients at Higher Risk for Other Health Issues

July 29, 2016 Inflammatory effects of disease can impact entire body, expert says

Eczema’s Effect on Patient Health Can Be Extensive

July 29, 2016 Patients diagnosed with eczema may have increased risk for other conditions as well

Health Care Workers’ Gloves Strong Source of Contamination

June 27, 2016 Clear evidence that gloves of health care workers contaminate hospital surfaces with bacteria

ASCO: Phase I Cancer Drug Trials Benefit From Precision Medicine

May 20, 2016 Better outcomes for patients whose treatment is selected based on molecular characteristics of tumor

ASCO: Pembrolizumab Improves Survival in Melanoma

May 19, 2016 Three-year overall survival rate of 40 percent; median overall survival of 24.4 months

ATS: Aggressive Melanoma Linked to Severe, Untreated Sleep Apnea

May 17, 2016 Study highlights the importance of diagnosing and treating obstructive sleep apnea

AACR: Pembrolizumab Effective Against Merkel-Cell Carcinoma

April 19, 2016 Intravenous medication blocks programmed death 1 (PD-1) immune inhibitory pathway

AACR: Nivolumab Appears to Up Survival in Advanced Melanoma

April 19, 2016 One-third of study participants lived five years or more after starting treatment

AACR: SPF 30 Delays Melanoma in Preclinical Model

April 18, 2016 Study results suggest scientists can use mice to find better ways to prevent melanoma in humans

ENDO: Tanning May Limit Skin’s Ability to Produce Vitamin D

April 05, 2016 Even those with significant sun exposure can have low levels of this essential vitamin